A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second‐Line Treatment of Metastatic KRAS Mutant Colorectal Adenocar...

por Hecht, J. Randolph, Benson, Al B., Vyushkov, Dmitry, Yang, Yingsi, Bendell, Johanna, Verma, Udit
Publicado 2017

Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs

por Hao, Zhonglin, Parasramka, Saurabh, Chen, Quan, Jacob, Aasems, Huang, Bin, Mullett, Timothy, Benson, Al B
Publicado 2022

A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma...

por Benson, Al B., Wainberg, Zev A., Hecht, J. Randolph, Vyushkov, Dmitry, Dong, Hua, Bendell, Johanna, Kudrik, Fred
Publicado 2017

Preoperative assessment of lymph node metastasis in Colon Cancer patients using machine learning: a pilot study

por Eresen, Aydin, Li, Yu, Yang, Jia, Shangguan, Junjie, Velichko, Yury, Yaghmai, Vahid, Benson, Al B., Zhang, Zhuoli
Publicado 2020

Randomized Phase II Trial of Irinotecan/Docetaxel or Irinotecan/Docetaxel Plus Cetuximab for Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study

por Burtness, Barbara, Powell, Mark, Catalano, Paul, Berlin, Jordan, Liles, Darla K., Chapman, Andrew E., Mitchell, Edith, Benson, Al B.
Publicado 2016

Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumors

por Kirkwood, John M., Tarhini, Ahmad, Sparano, Joseph A., Patel, Prapti, Schiller, Joan H., Vergo, Maxwell T., Benson, Al B., Tawbi, Hussein
Publicado 2012

MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal adenocarcinoma

por Eresen, Aydin, Yang, Jia, Shangguan, Junjie, Li, Yu, Hu, Su, Sun, Chong, Velichko, Yury, Yaghmai, Vahid, Benson, Al B., Zhang, Zhuoli
Publicado 2020

TELEPRO: Patient‐Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World

por Strosberg, Jonathan, Joish, Vijay N., Giacalone, Susan, Perez‐Olle, Raul, Fish‐Steagall, Ann, Kapoor, Kanika, Dharba, Sam, Lapuerta, Pablo, Benson, Al B.
Publicado 2019

Docetaxel, Oxaliplatin, and 5‐Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long‐Term Follow‐Up

por Rosenberg, Ari Joseph, Rademaker, Alfred, Hochster, Howard S., Ryan, Theresa, Hensing, Thomas, Shankaran, Veena, Baddi, Lisa, Mahalingam, Devalingam, Mulcahy, Mary F., Benson, Al B.
Publicado 2019

Role of Oncology Advanced Practitioners to Enhance Clinical Research

por Braun-Inglis, Christa, Boehmer, Leigh M., Zitella, Laura J., Hoffner, Brianna, Shvetsov, Yurii B., Berenberg, Jeffrey L., Oyer, Randall A., Benson, Al B.
Publicado 2022

Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers

por Reyngold, Marsha, Niland, Joyce, ter Veer, Anna, Bekaii-Saab, Tanios, Lai, Lily, Meyer, Joshua E., Nurkin, Steven J., Schrag, Deborah, Skibber, John M., Benson, Al B., Weiser, Martin R., Crane, Christopher H., Goodman, Karyn A.
Publicado 2017

Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer

por McGarrah, Patrick, Hubbard, Joleen, Novotny, Paul J., Branda, Megan E., Sargent, Daniel S., Morton, Roscoe F., Fuchs, Charles S., Benson, Al B., Williamson, Stephen K., Findlay, Brian P., Alberts, Steven R., Goldberg, Richard M., Sloan, Jeff A.
Publicado 2023

Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer

por Overman, Michael, Javle, Milind, Davis, Richard E, Vats, Pankaj, Kumar-Sinha, Chandan, Xiao, Lianchun, Mettu, Niharika B, Parra, Edwin R, Benson, Al B, Lopez, Charles D, Munugalavadla, Veerendra, Patel, Priti, Tao, Lin, Neelapu, Sattva, Maitra, Anirban
Publicado 2020

Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer

por Sinicrope, Frank A, Shi, Qian, Hermitte, Fabienne, Zemla, Tyler J, Mlecnik, Bernhard, Benson, Al B, Gill, Sharlene, Goldberg, Richard M, Kahlenberg, Morton S, Nair, Suresh G, Shields, Anthony F, Smyrk, Thomas C, Galon, Jerome, Alberts, Steven R
Publicado 2020

Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061

por Van Cutsem, Eric, Amonkar, Mayur, Fuchs, Charles S., Alsina, Maria, Özgüroğlu, Mustafa, Bang, Yung-Jue, Chung, Hyun Cheol, Muro, Kei, Goekkurt, Eray, Benson, Al B., Sun, Weijing, Wainberg, Zev A., Norquist, Josephine M., Chen, Xinqun, Shih, Chie-Schin, Shitara, Kohei
Publicado 2021

Strong Signature of Natural Selection within an FHIT Intron Implicated in Prostate Cancer Risk

por Ding, Yan, Larson, Garrett, Rivas, Guillermo, Lundberg, Cathryn, Geller, Louis, Ouyang, Ching, Weitzel, Jeffrey, Archambeau, John, Slater, Jerry, Daly, Mary B., Benson, Al B., Kirkwood, John M., O'Dwyer, Peter J., Sutphen, Rebecca, Stewart, James A., Johnson, David, Nordborg, Magnus, Krontiris, Theodore G.
Publicado 2008

Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group

por Yoon, Harry H, Catalano, Paul J, Murphy, Kathleen M, Skaar, Todd C, Philips, Santosh, Powell, Mark, Montgomery, Elizabeth A, Hafez, Michael J, Offer, Steven M, Liu, Geoffrey, Meltzer, Stephen J, Wu, Xifeng, Forastiere, Arlene A, Benson, Al B, Kleinberg, Lawrence R, Gibson, Michael K
Publicado 2011

Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance)

por Fadelu, Temidayo, Zhang, Sui, Niedzwiecki, Donna, Ye, Xing, Saltz, Leonard B., Mayer, Robert J., Mowat, Rex B., Whittom, Renaud, Hantel, Alexander, Benson, Al B., Atienza, Daniel M., Messino, Michael, Kindler, Hedy L., Venook, Alan, Ogino, Shuji, Ng, Kimmie, Wu, Kana, Willett, Walter, Giovannucci, Edward, Meyerhardt, Jeffrey, Bao, Ying, Fuchs, Charles S.
Publicado 2018

Associations Between Unprocessed Red Meat and Processed Meat With Risk of Recurrence and Mortality in Patients With Stage III Colon Cancer

por Van Blarigan, Erin L., Ou, Fang-Shu, Bainter, Tiffany M., Fuchs, Charles S., Niedzwiecki, Donna, Zhang, Sui, Saltz, Leonard B., Mayer, Robert J., Hantel, Alexander, Benson, Al B., Atienza, Daniel, Messino, Michael, Kindler, Hedy L., Venook, Alan P., Ogino, Shuji, Sanoff, Hanna K., Giovannucci, Edward L., Ng, Kimmie, Meyerhardt, Jeffrey A.
Publicado 2022

Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)

por Kemeny, M. Margaret, Zhao, Fengmin, Forastiere, Arlene A., Catalano, Paul, Hamilton, Stanley R., Miedema, Brent W., Dawson, Nancy A., Weiner, Louis M., Smith, Brian D., Mason, Bernard A., Graziano, Stephen L., Gilman, Paul B., Venook, Alan P., Pinto, Harlan A., Whitehead, Robert P., O’Dwyer, Peter J., Benson, Al B.
Publicado 2022